Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Liu Y, Chen M. Letter regarding "Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways". Clin Mol Hepatol 2023;29:163-164. [PMID: 36300328 PMCID: PMC9845684 DOI: 10.3350/cmh.2022.0326] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/21/2022] [Accepted: 10/25/2022] [Indexed: 02/02/2023] Open

For:	Liu Y, Chen M. Letter regarding "Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways". Clin Mol Hepatol 2023;29:163-164. [PMID: 36300328 PMCID: PMC9845684 DOI: 10.3350/cmh.2022.0326] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/21/2022] [Accepted: 10/25/2022] [Indexed: 02/02/2023] Open

Number

Cited by Other Article(s)

Lee SM, Jun DW. Correspondence on Letter regarding "Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways". Clin Mol Hepatol 2023;29:171-172. [PMID: 36353765 PMCID: PMC9845663 DOI: 10.3350/cmh.2022.0381] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/06/2022] [Accepted: 11/07/2022] [Indexed: 11/12/2022] Open